This topic contains a solution. Click here to go to the answer

Author Question: Schroeter et al., (2009 ) noted that the most reliable predictor of progression from mild cognitive ... (Read 25 times)

Starlight

  • Hero Member
  • *****
  • Posts: 567
Schroeter et al., (2009 ) noted that the most reliable predictor of progression from mild cognitive impairment to Alzheimer's disease was:
 
  a) Head injury
  b) Atrophy in the parietal lobes
  c) Hypometabolism/hypoperfusion in the inferior parietal lobules
  d) Changes in the posterior cingulate cortex and precuneus

Question 2

Plaques, which develop as part of Alzheimer's disease, are:
 
  a) Fatty deposits in areas of the brain.
  b) Cholesterol remains from poor diet.
  c) Remnants of lost neurons and a waxy protein.
  d) Equivalent to neurofibrillary tangles.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

c

Answer to Question 2

You are a life saver.




Starlight

  • Member
  • Posts: 567
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


marict

  • Member
  • Posts: 304
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library